West Pharmaceutical Services Inc.

Company Overview

West Pharmaceutical Services Inc. is a U.S.-based pharmaceutical company engaged in the manufacture of packaging components and delivery systems for injectable drugs and healthcare products. It offers the SmartDose electronic wearable injector, which is a delivery system designed to improve the patient experience and to encourage medication adherence. Headquartered in Exton, Pa., West serves customers in many countries.

The company was established in 1923 and offers injectables and other healthcare products. The company operates through two segments of business: proprietary products and contract manufactured products. The company provides a variety of products in the pharmaceutical industry: containment, packaging and drug products. It provides vial containment solutions, pre-fillable systems, self-injection systems, cartridge systems and components, intradermal delivery and proprietary products. The company provides quality packaging of drug products to the customer through its packaging component: stoppers, sealer and vials.

The company provides consistent syringe systems with accurate dosage: Nova Pure Syringe Plungers, Fluro-Tec Plungers and Envision Plungers. The company provides analytical services including extractables and leachables, particle analysis, container closure integrity and packaging systems. The company enhances the quality of products through various components and coatings: wester components, sterilized components, films and coatings. The company develops and manufactures devices for drug delivery solutions to ensure safe delivery of pharmaceutical products. It includes auto injectors, pen injectors, pulmonary delivery devices, oral dispensing devices and solid dose injectors.

The company offers biologic drug products which stimulate the body’s internal system to treat chronic illness. The company offers pharmaceutical products through network and regional distributors. The manufacturers design and deliver automated assembly products and devices for surgical, diagnostic, ophthalmic and other fields.

Financial Highlights (FY 2024)

Company's Business Segments

• Proprietary Products : This segment provides offers packaging, containment solutions, drug delivery systems, analytical lab services, other integrated services and solutions primarily to biologic, generic, and pharmaceutical drug customers.
• Contract-Manufactured Products : This segment offers completely integrated business focused on the design, manufacture, and automated assembly of complicated devices primarily for pharmaceutical, diagnostic, and medical device customers.